Ningbo Menovo Pharmaceutical Co (SHSE:603538) GF Value Rank : 8 (As of Jun. 20, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ningbo Menovo Pharmaceutical Co GF Value Rank?

Ningbo Menovo Pharmaceutical Co has the GF Value Rank of 8.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Ningbo Menovo Pharmaceutical Co's GF Value Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Ningbo Menovo Pharmaceutical Co's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ningbo Menovo Pharmaceutical Co's GF Value Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ningbo Menovo Pharmaceutical Co's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Ningbo Menovo Pharmaceutical Co's GF Value Rank falls into.

Ningbo Menovo Pharmaceutical Co GF Value Rank Related Terms

Thank you for viewing the detailed overview of Ningbo Menovo Pharmaceutical Co's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ningbo Menovo Pharmaceutical Co Ltd (SHSE:603538) » Definitions » GF Value Rank

Traded in Other Exchanges

N/A

Address

No.999,Yangfan Road, Room 1406, No.1, High-tech Zone, Ningbo, CHN, 315040

Website

http://www.menovopharm.com

Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.

Executives

Xu Jian	senior management
Cao Qian	Director
Yao Fang	Director
Ying Gao Feng	Director
Sun Yan	Director
Shi Jian Xiang	Director
Wu Feng Yun	Director
Tu Ying	Director
Yao Cheng Zhi	Director
Zheng Hui Lin	Supervisors
Jiao Hua	senior management

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Headlines

No Headlines